The agency issued a PDUFA target action date of June 14, 2027. The FDA has accepted for review a new drug application (NDA) seeking approval of UGN-103 (mitomycin) for intravesical solution for ...
Take a look through some of the notable data presentations at this year's ESMO Congress. Taking place October 23 to 27 in Madrid, Spain, the 2026 European Society for Medical Oncology (ESMO) Congress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results